Real-world evidence on the effectiveness and safety of gliclazide MR 60 mg in Bangladeshi patients with Type II diabetes during fasting: a sub-analysis from the global DIA-RAMADAN study.
- DOI
- 10.57264/cer-2023-0132
- Published
- 2024 Feb
- Container
- Journal of comparative effectiveness research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.57264/cer-2023-0132,
title = {Real-world evidence on the effectiveness and safety of gliclazide MR 60 mg in Bangladeshi patients with Type II diabetes during fasting: a sub-analysis from the global DIA-RAMADAN study.},
author = {Uddin MF and Khan MA and Selim S and Sultana N and Sayem MA and Iftekhar MM and Habib MB and Akter N and Khan S},
year = {2024},
journal = {Journal of comparative effectiveness research},
doi = {10.57264/cer-2023-0132},
url = {https://doi.org/10.57264/cer-2023-0132}
}RIS
TY - JOUR TI - Real-world evidence on the effectiveness and safety of gliclazide MR 60 mg in Bangladeshi patients with Type II diabetes during fasting: a sub-analysis from the global DIA-RAMADAN study. AU - Uddin MF AU - Khan MA AU - Selim S AU - Sultana N AU - Sayem MA AU - Iftekhar MM AU - Habib MB AU - Akter N AU - Khan S PY - 2024 JO - Journal of comparative effectiveness research DO - 10.57264/cer-2023-0132 UR - https://doi.org/10.57264/cer-2023-0132 ER -
APA
MF, U., MA, K., S, S., N, S., MA, S., MM, I., MB, H., N, A., & S, K. (2024). Real-world evidence on the effectiveness and safety of gliclazide MR 60 mg in Bangladeshi patients with Type II diabetes during fasting: a sub-analysis from the global DIA-RAMADAN study.. Journal of comparative effectiveness research. https://doi.org/10.57264/cer-2023-0132
Source records
- pubmed · retrieved 2026-09-27T11:56:26.608Z